| |
| |
|
| Insider
Information: |
Ryan Jason |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
188,356 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$5,420,886 |
|
|
| Total
Shares |
188,356 |
|
|
| Total
Value |
$5,420,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 1,777.6%
|
632.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
Chief Financial Officer |
2018-07-31 |
0 |
2014-04-16 |
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2024-01-11 |
0 |
2024-01-11 |
188,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-10-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-12-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-12-15 |
4 |
AS |
$21.55 |
$50,880 |
D/D |
(2,361) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-10-02 |
4 |
S |
$38.80 |
$122,375 |
D/D |
(3,154) |
63,484 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-01-03 |
4 |
S |
$17.41 |
$56,391 |
D/D |
(3,239) |
56,183 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$465,054 |
D/D |
(3,403) |
49,170 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-07-01 |
4 |
S |
$17.39 |
$59,422 |
D/D |
(3,417) |
71,281 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-16 |
4 |
AS |
$74.30 |
$256,261 |
D/D |
(3,449) |
52,573 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-04-16 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-04-16 |
4 |
AS |
$26.36 |
$93,335 |
D/D |
(3,541) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-07-15 |
4 |
AS |
$27.22 |
$96,387 |
D/D |
(3,541) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-07-15 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-08-15 |
4 |
AS |
$25.13 |
$88,982 |
D/D |
(3,541) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-08-15 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-11-17 |
4 |
AS |
$24.90 |
$88,185 |
D/D |
(3,541) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-11-17 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,278 |
17,114 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-05 |
4/A |
S |
$24.20 |
$115,498 |
D/D |
(4,773) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-05 |
4/A |
OE |
$0.08 |
$382 |
D/D |
4,773 |
4,773 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-08-19 |
4 |
OE |
$7.12 |
$35,600 |
D/D |
5,000 |
66,148 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-07-13 |
4 |
AS |
$39.77 |
$202,191 |
D/D |
(5,084) |
66,638 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-06-02 |
4 |
AS |
$40.00 |
$222,920 |
D/D |
(5,573) |
78,405 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
AS |
$74.87 |
$467,959 |
D/D |
(6,139) |
56,023 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-07-06 |
4 |
S |
$38.84 |
$259,568 |
D/D |
(6,683) |
71,722 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$952,835 |
D/D |
(6,955) |
42,215 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
